Six months into the pandemic. A review of skin manifestations in
            <scp>SARS‐CoV</scp>
            ‐2 infection

Burlando, Martina; Russo, Roberto; Cozzani, Emanuele; Parodi, Aurora

doi:10.1111/dth.14641

Cited by 3 publications

(3 citation statements)

References 40 publications

(118 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since finalizing the data collection, additional research has been completed, and there is a better understanding of the COVID-19 disease process and how it affects the patient’s body, particularly the skin. This study’s results align and are consistent with the findings of previous and subsequent case studies and research 21–32 …”

Section: Discussionsupporting

confidence: 90%

See 1 more Smart Citation

Examining Violaceous Skin Discoloration during the COVID-19 Pandemic: Conducting Research in Resource Scarcity

Savage

Lieder

Liu

et al. 2023

Adv Skin Wound Care

View full text Add to dashboard Cite

OBJECTIVETo describe the observed patterns and presentations of violaceous discoloration that appeared to be related to the COVID-19 disease process.METHODSThis retrospective observational cohort study included adults who were COVID-19 positive with purpuric/violaceous lesions in pressure-adjacent areas of the gluteus without preexisting pressure injury. Patients were admitted to an ICU at a single quaternary academic medical center between April 1 and May 15, 2020. Data were compiled by review of the electronic health record. The wounds were described by location, tissue type (violaceous, granulation, slough, eschar), wound margin (irregular, diffuse, nonlocalized), and periwound condition (intact).RESULTSA total of 26 patients were included in the study. Purpuric/violaceous wounds were found predominantly on White (92.3%) men (88.0%) aged 60 to 89 years (76.9%) with a body mass index 30 kg/m2 or higher (46.1%). The majority of wounds were located on the sacrococcygeal (42.3%) and fleshy gluteal regions (46.1%).CONCLUSIONSWounds were heterogeneous in appearance (poorly defined violaceous skin discoloration of acute onset), and the patient population had clinical characteristics similar to acute skin failure (eg, concomitant organ failures and hemodynamic instability). Additional larger population-based studies with biopsies may assist in finding patterns related to these dermatologic changes.

show abstract

Section: Discussionsupporting

confidence: 90%

“…This study's results align and are consistent with the findings of previous and subsequent case studies and research. [21][22][23][24][25][26][27][28][29][30][31][32]…”

Section: Discussionmentioning

confidence: 99%

Examining Violaceous Skin Discoloration during the COVID-19 Pandemic: Conducting Research in Resource Scarcity

Savage

Lieder

Liu

et al. 2023

Adv Skin Wound Care

View full text Add to dashboard Cite

show abstract

“…During the first months, cutaneous manifestations of the SARS‐CoV‐2 infection were continuously being reported. A potential correlation between cutaneous aspects and severity degrees of the disease has been hypothesized, albeit never demonstrated 1 . However, there is considerable interest surrounding the dermatological aspects of COVID‐19.…”

Section: Figurementioning

confidence: 99%

COVID‐19 “second wave” and vaccines: the dermatologists’ perspective

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

Six months into the pandemic. A review of skin manifestations in SARS‐CoV ‐2 infection

Burlando

Russo

Cozzani

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

During the COVID‐19 pandemic, various cutaneous manifestations have been described as associated with SARS‐CoV2 infection. It is debated if skin lesions could represent a diagnostic or prognostic indicator. Specifically, it is unclear whether skin lesions may be used to perform an early diagnosis and/or to predict worse outcomes. In this review, we described the cutaneous signs so far reported as COVID‐19‐related and discussed their incidence, clinico‐pathological features, and diagnostic and prognostic value.

show abstract

Six months into the pandemic. A review of skin manifestations in SARS‐CoV ‐2 infection

Cited by 3 publications

References 40 publications

Examining Violaceous Skin Discoloration during the COVID-19 Pandemic: Conducting Research in Resource Scarcity

Examining Violaceous Skin Discoloration during the COVID-19 Pandemic: Conducting Research in Resource Scarcity

COVID‐19 “second wave” and vaccines: the dermatologists’ perspective

Six months into the pandemic. A review of skin manifestations in SARS‐CoV ‐2 infection

Contact Info

Product

Resources

About